Table 1.
Patients’ characteristics
| Primary tumor | NACa | |
|---|---|---|
| No of patients in phase of study | 15 | 5 |
| Gender (Male/Female) | 13/2 | 5 |
| Age (years) | 67 (55–79) | 65 (57–69) |
| ASA-score | 2 (1–3) | 2 |
| BMI (kg/m2) | 27 (23–31) | 26 (23–30) |
| Treatment modality | ||
| TUR-BT and surveillance | 5 | N/A |
| TUR-BT and BCG | 7 | N/A |
| TUR-BT, NAC, RC and EPLND | 2 | 5 |
| TUR-BT, BCG and RCb | 1 | N/A |
Mean values and range are given, when feasible. ASA-score The American Society of Anesthesiologists physical status grading system; BMI body mass index, TUR-BT Transurethral resection of bladder tumor, BCG Bacillus-Calmette-Guerin bladder instillations, RC radical cystectomy, EPLND extended pelvic lymph node dissection, N/A not applicable
a2 patients participated in both phases of the study
bRC due to disease progression